Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

10.1245/s10434-006-9248-9
Annals of Surgical Oncology 14:577-582 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caudle, A. S.
Right arrow Articles by Kim, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caudle, A. S.
Right arrow Articles by Kim, H. J.

Original Article

Complications Associated with Neoadjuvant Radiotherapy in the Multidisciplinary Treatment of Retroperitoneal Sarcomas

Abigail S. Caudle, MD1, Joel E. Tepper, MD2, Benjamin F. Calvo, MD1, Michael O. Meyers, MD1, Lav K. Goyal, MD2, William G. Cance, MD3 and Hong Jin Kim, MD1

1 Department of Surgery, Division of Surgical Oncology, University of North Carolina School of Medicine, 3010 Old Clinic Building, CB #7213, Chapel Hill, NC 27599, USA
2 Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA
3 Department of Surgery, University of Florida, Gainesville, FL 32610-0286, USA

Correspondence: Address correspondence and reprint requests to: Hong Jin Kim, MD; E-mail: kimhj{at}med.unc.edu

Introduction: Retroperitoneal sarcomas (RPS) remain a therapeutic challenge due to high local recurrence rates. Preoperative RT offers theoretical advantages in the multidisciplinary care of RPS. The purpose of our study was to evaluate our experience using preoperative radiotherapy (PRT) in the treatment of RPS.

Methods: This is a single-institution review of patients with RPS treated with PRT from 1994 until 2004. Three radiation oncologists and four surgical oncologists were involved. Medical records, tumor registries, and death records were reviewed.

Results: Fourteen patients were included; nine were treated for primary presentation and five for recurrent disease. Histologic grade was grade I (n = 3), grade II (n = 3), and grade III (n = 8). Five patients received additional IORT. Radiotherapy complications were generally mild, including nausea (n = 3), diarrhea (n = 1), dehydration (n = 1), anemia (n = 1), and skin changes (n = 1); one required early cessation due to nausea. Thirteen patients had gross negative margins; while 7/13 had negative microscopic margins. Operative complications included anastomotic bleeding (n = 1), fluid collections (n = 2), ileus (n = 3), ascites (n = 2), temporary leg weakness (n = 1), and uncomplicated wound infections (n = 2). In patients with R0 or R1 resections, one and two year local control rates were 64 and 50%. Overall survival for all patients was 90% at 1 year and 74% at 2 years with median survival of 21 months.

Conclusion: PRT and IORT can be administered effectively in carefully selected patients with resectable RPS. Larger multi-center studies are needed to delineate the role of PRT and IORT to improve local recurrence and survival rates in the treatment of RPS.

Key Words: Retroperitoneal sarcoma • Radiotherapy • Complications




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
P. W. T. Pisters
Retroperitoneal Sarcomas--An SOS to Colleagues in Europe
Ann. Surg. Oncol., June 1, 2007; 14(6): 1787 - 1789.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.